Michael A. den Bakker

Maasstad Ziekenhuis

Papers

3

Total Citations

67

H-Index

3

About

Michael A. den Bakker is a leading pathologist whose research has profoundly shaped the surgical management of prostate cancer, particularly through the implementation of the NeuroSAFE technique. His work centers on optimizing the balance between oncological safety and functional preservation in radical prostatectomy. Den Bakker’s major contributions include demonstrating that intraoperative neurovascular structure-adjacent frozen-section examination (NeuroSAFE) significantly increases the rate of nerve-sparing surgery without compromising cancer control, a finding published in a 2022 study with 40 citations. He further validated these benefits by showing improved postoperative urinary continence and erectile function following NeuroSAFE adoption, as reported in a 2023 paper with 22 citations. Beyond these high-impact studies, den Bakker has also conducted rigorous prospective research on prostatectomy specimen sampling protocols, challenging the necessity of complete sampling for pT3a tumors and surgical margin assessment. His work has directly influenced clinical guidelines and surgical practice, helping to spare thousands of men from unnecessary functional loss while maintaining effective cancer treatment. Den Bakker’s research exemplifies how meticulous pathological analysis can drive meaningful improvements in patient quality of life.

Research Focus

Key Achievements

3
H-Index
3
Papers
67
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
<scp>NeuroSAFE</scp> in radical prostatectomy increases the rate of nerve‐sparing surgery without affecting oncological outcome
40 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Maasstad Ziekenhuis

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago